The efficacy of alendronate for the treatment of thalassemia-associated osteoporosis: a randomized controlled trial

BACKGROUND: With adequate blood transfusion and iron chelation, thalassemia patients have a longer life expectancy and experience long-term metabolic complications, including osteoporosis, fractures, and bone pain. Alendronate, an oral bisphosphonate, is currently used to treat various types of oste...

Descripción completa

Detalles Bibliográficos
Autores principales: Piriyakhuntorn, Pokpong, Tantiworawit, Adisak, Phimphilai, Mattabhorn, Srichairatanakool, Somdet, Teeyasoontranon, Waralee, Rattanathammethee, Thanawat, Hantrakool, Sasinee, Chai-Adisaksopha, Chatree, Rattarittamrong, Ekarat, Norasetthada, Lalita, Fanhchaksai, Kanda, Charoenkwan, Pimlak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210588/
https://www.ncbi.nlm.nih.gov/pubmed/37251676
http://dx.doi.org/10.3389/fendo.2023.1178761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210588/
https://www.ncbi.nlm.nih.gov/pubmed/37251676
http://dx.doi.org/10.3389/fendo.2023.1178761

Ejemplares similares